ADMA Biologics Inc (ADMA)

Debt-to-capital ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Long-term debt US$ in thousands 72,337 130,594 142,833 94,866 92,969
Total stockholders’ equity US$ in thousands 349,018 135,206 151,974 141,173 88,249
Debt-to-capital ratio 0.17 0.49 0.48 0.40 0.51

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $72,337K ÷ ($72,337K + $349,018K)
= 0.17

The Debt-to-Capital ratio for ADMA Biologics Inc has shown fluctuations over the past five years. Starting at 0.51 in December 2020, the ratio decreased to 0.40 by December 2021, indicating a lower reliance on debt in the company's capital structure. However, the ratio increased to 0.48 in December 2022 and further to 0.49 in December 2023, suggesting a higher proportion of debt in the capital mix. Notably, there was a significant decrease in the ratio to 0.17 by December 2024, signifying a potential reduction in debt relative to the company's overall capital. Overall, monitoring this metric is crucial in understanding ADMA Biologics Inc's leverage and financial risk management strategies.